Company / FCF Margin
Integra Lifesciences Holdings FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-1.9%
FY2025
5-year range
-1.9% / 17.1%
FY2021-FY2025
Trend
-222.6%
vs FY2024
Sector context
#120 of 145
Health Care
What the data says
FCF Margin changed -223% YoY in FY2025, a notable deviation from the 9-year average annual change of -27%.
Based on SEC 10-K filings.
-1.9% in FY2025 with a 5-year CAGR of -13.9%.
Declined from 4.7% to -1.9% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -16.2pp
- 5-Year Change
- -13.9pp
- 10-Year Change
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 145This company -1.9% Sector average -207.5%
▼
+99.1% above sector average
Key checks
Key Insights
- Integra Lifesciences Holdings's fcf margin has declined for 4 consecutive years.
- In FY2025, fcf margin decreased 222.6% year-over-year.
- Currently 205.6pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -1.9% | -222.6% |
| FY2024 | 1.6% | -67.3% |
| FY2023 | 4.7% | -66.8% |
| FY2022 | 14.3% | -16.8% |
| FY2021 | 17.1% | +42.6% |
| FY2020 | 12.0% | +12.7% |
| FY2019 | 10.7% | +28.9% |
| FY2018 | 8.3% | +2.3% |
| FY2017 | 8.1% | +42.4% |
| FY2016 | 5.7% | -29.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026